Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeremy M Rosenblum"'
Autor:
Dean Lee, Jeremy M Rosenblum, Mitchell S Cairo, Mario Marcondes, Timothy Cripe, Katherine Miller, Xiaokui Mo, Elaine Mardis, Wen Luo, Hai Hoang, Hongwen Zhu, Shiori Eguchi, Meijuan Tian, Yanling Liao, Janet Ayello, Mark Currier
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 9 (2024)
Background Pediatric patients with recurrent/metastatic Ewing sarcoma (ES) have a dismal 5-year survival. Novel therapeutic approaches are desperately needed. Natural killer (NK) cell number and function are low in ES patient tumors, in large part du
Externí odkaz:
https://doaj.org/article/7881952bc95e40f5ab2467d1369d588d
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The prognosis of patients with relapsed or progressive B cell (CD20+) non-Hodgkin’s lymphoma (B-NHL), including Burkitt lymphoma (BL), is dismal due to chemoradiotherapy resistance. Novel therapeutic strategies are urgently needed. N-820
Externí odkaz:
https://doaj.org/article/752d96bf91744f83a32d2522239e2b10
Autor:
Wen Luo, Hai Hoang, Katherine E. Miller, Hongwen Zhu, Serena Xu, Xiaokui Mo, Elizabeth A. R. Garfinkle, Heather Costello, Saranga Wijeratne, Wiebke Chemnitz, Ronan Gandhi, Yanling Liao, Janet Ayello, Aliza Gardenswartz, Jeremy M. Rosenblum, Kevin A. Cassady, Elaine R. Mardis, Dean A. Lee, Timothy P. Cripe, Mitchell S. Cairo
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-17 (2024)
Abstract Background Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the expression of anti-phagocytic signals, most commonly CD47. In Ewing sarcoma (ES), we found that tumo
Externí odkaz:
https://doaj.org/article/ef612054309d4f2fb16fbb5249bba11b
Autor:
Patrick Soon-Shiong, Dean A. Lee, Yaya Chu, Gaurav Nayyar, Jeffrey T Safrit, Susiyan Jiang, Jeremy M. Rosenblum, Mitchell S. Cairo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Children with recurrent and/or metastatic osteosarcoma (OS), neuroblastoma (NB) and glioblastoma multiforme (GBM) have a dismal event-free survival (
Externí odkaz:
https://doaj.org/article/88879cd3923d4e4d9638289ac32ef8a0